Dr. Dominick George Sudano, MD

Dr. Sudano practices at Catalina Pointe Arthritis & Rheumatology Specialists in Tucson, Arizona.

Dr. Sudano's NPI, 1275774937, was assigned on March 10, 2009. Dr. Sudano holds Arizona license 44910.

Dr. Sudano's primary practice is Catalina Pointe Arthritis & Rheumatology Specialists, at 7520 N Oracle Rd, Tucson, AZ 85704 in Pima County. The practice phone is (520) 408-1133.

Dr. Sudano's primary practice is Catalina Pointe Arthritis & Rheumatology Specialists in Tucson, Arizona. Dr. Sudano is also affiliated with Tucson Medical Center. The medical group on file is Sells Hospital. Dmand AI also links Dr. Sudano to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sudano practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Sudano's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Sudano is licensed in Arizona.

CMS data shows 9,128 Medicare services from Dr. Sudano across 11 procedure codes in 2024, for 380 Medicare patients. Medicare paid $282,881 for them. Every service was in an office.

CMS counts 380 Medicare patients who saw Dr. Sudano in 2024. The largest group is 65 to 74, with 176 patients. 75% of them have arthritis, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sudano's median patient age at 71, with 72% women.

In 2024, Dr. Sudano wrote 3,255 Medicare Part D claims for 469 patients. 82% of them were for generic drugs. CMS names the drug for 2,946 of them, across 46 drugs with 11 or more claims each, at $2,287,129 in total drug cost. In 2023, CMS named 2,903 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sudano for performance year 2024, reported as part of a group. Dr. Sudano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sudano as offering telehealth.

Dmand AI links 6 papers to Dr. Sudano, published from 2018 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Immunosuppressive Agents. Dr. Sudano has published most often in J Clin Rheumatol. Dr. Sudano's most frequent co-authors are Jawad Bilal, MD, Shubha Kollampare, MD and Chian Kent Kwoh, MD.

Dmand AI links Dr. Sudano to 10 clinical trials. Conditions studied include Axial Spondyloarthritis, Lupus Erythematosus, Systemic and Connective Tissue Diseases. Eli Lilly and Company sponsors the most, 10. Open Payments lists research payments to Dr. Sudano that name 4 trials.

CMS Open Payments shows 57 general payments to Dr. Sudano from 12 drug and device companies from 2016 to 2025. Grants make up the largest share, 58% of the total. Eli Lilly and Company paid the most, $12,725. It also lists 5 research payments totaling $4,880 from 2016 to 2020, naming 4 clinical trials.